JPRN-UMIN000031860招募中未知
TR study of "A multi-center proof-of-concept phase2 study of encorafenib + binimetinib + cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer (BIGBANG study)" - BIGBANG TR
ational Cancer Center Hospital East0 个研究点目标入组 36 人开始时间: 2018年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
TR accompanied with the study titled A multicenter phase II study of Nivolumab monotherapy in recurrent and/or metastatic gastrointestinal cancer patients with high Tumor Mutation Burden (TMB-H).Colorectal cancer, Gastric cancer, Esophageal cancer, Biliary tract cancer, Pancreatic cancer, and Other Solid cancerJPRN-UMIN000033560ational Cancer Center Hospital East70
已完成
不适用
TR study of "A multicenter phase II study of eribulin monotherapy in patients with BRAF V600E mutant metastatic colorectal cancer (BRAVERY study)"BRAF V600E mutant metastatic colorectal cancerJPRN-UMIN000031552Aichi Cancer Center Hospital27
进行中（未招募）
不适用
A multi-centre and prospective trial to evaluate the effects on mul-tiple sclerosis related fatigue during treatment with Tysabri® in patients with relapsing remitting multiple sclerosis over the course of 12 months - TYNERGYMutiple sclerosis related fatigue in subjects with relapsing remitting multiple sclerosisMedDRA version: 9.1Level: LLTClassification code 10063399Term: Relapsing-remitting multiple sclerosisMedDRA version: 9.1Level: LLTClassification code 10016256Term: FatigueEUCTR2008-008065-35-SEBiogenIdec A/S200
进行中（未招募）
不适用
A Single-arm, Multicenter, Proof-of-concept Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects with Elevated Serum Calcium Despite Recent Treatment with IV Bisphosphonates - NDEUCTR2009-009756-21-ITAmgen Inc33
进行中（未招募）
不适用
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum CalciumHypercalcemia of malignancy (HCM)MedDRA version: 15.0Level: LLTClassification code 10020588Term: Hypercalcemia of malignancySystem Organ Class: 10014698 - Endocrine disordersEUCTR2009-009756-21-PLAmgen Inc33